Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Asian Stocks Down, With Yield Worries Creeping In

Published 22/02/2021, 02:34 pm
© Reuters.
AXJO
-
JP225
-
HK50
-
BARC
-
PFE
-
SVA
-
KS11
-
SSEC
-
SZI
-
22UAy
-

By Gina Lee

Investing.com – Asia Pacific stocks were mostly down on Monday morning, giving up earlier gains even as global COVID-19 vaccine programs advance and optimism continues to grow for an economic recovery.

Japan’s Nikkei 225 were up 0.26% by 10:32 PM ET (3:32 AM GMT).

South Korea’s KOSPI edged down 0.16%, with the Bank of Korea to hand down its policy decision on Thursday.

In Australia, the ASX 200 edge down 0.14%. Australia began its COVID-19 vaccine rollout earlier in the day and is set to report no local cases for a third consecutive day. The vaccines also saw Fitch maintain the country’s AAA credit rating, albeit with a negative outlook.

Hong Kong’s Hang Seng Index inched up 0.05%. The city received its first batch of Sinovac Biotech Ltd.'s (NASDAQ:SVA) Coronavac vaccine during the previous week, with registration for priority groups set to open on Tuesday.

China’s Shanghai Composite inched down 0.06% and the Shenzhen Component slid 1.21%.

The optimism saw a bond selloff continue Monday, with benchmark 10-year Treasury yields climbing to the highest in about a year and a slide in sovereign debt for both Australia and New Zealand. Progress on the $1.9 trillion stimulus packages proposed by U.S. President Joe Biden also contributed to the selloff.

“Yield curves have continued to steepen, as COVID infection rates decline further, reopening plans are discussed and a large U.S. fiscal stimulus package looks likely,” Barclays (LON:BARC) head of economics research. Christian Keller told Reuters.

“This in principle signals a better medium-term growth outlook for the U.S. and beyond, as other core yields curves are moving in the same direction … meanwhile, central banks seem set to look through this year’s inflation increase, keeping the curves’ front end anchored,” he added.

As vaccine rollouts continue globally, Israel said that the COVID-19 vaccine developed by Pfizer Inc. (NYSE:PFE) and BioNTech SE (F:22UAy) seemed to protect most recipients from infection. Although global progress against the pandemic drove investor sentiment up, concerns about the reflation trade driving yields too high are staring to creep in.

Investors will be watching whether Federal Reserve Chairman Jerome Powell shows any signs of concerns over higher long-term borrowing costs when he delivers the Fed’s semi-annual monetary policy report to the Senate Banking Committee on Tuesday.

Across the Pacific Ocean, the Reserve Bank of Australia resumed purchases of three-year securities to defend its yield target.

Investors will also look to a virtual meeting of Group of 20 (G20) finance ministers and central bankers, due to take place on Friday. U.S. Treasury Secretary Janet Yellen will be among the attendees.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.